DAUGS, EDWARD D.,HAGEN, ERIC J.,HANKO, JASON A.,LOUKS, DAVID H.
申请号：
CA2606279
公开号：
CA2606279C
申请日:
2006.04.20
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The present invention provides crystalline solid and amorphous forms of (-)-halofenate. The crystalline solid forms may be used in various pharmaceuticalcompositions, and are particularly effective for the prevention and/ortreatment of conditions associated with blood lipid deposition in a mammal,particularly those diseases related to Type 2 diabetes and hyperlipidemia. Theinvention also relates to a method for preventing or treating Type 2 diabetesand hyperlipidemia in a mammal comprising the step of administering atherapeutically effective amount of crystalline solid and amorphous forms of (-)-halofenate.
